The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems (Q40861115)

24 September 2017

1 reference

title

The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems (English)

1 reference

24 September 2017

1 reference

2

1 reference

24 September 2017

Lawrence AD

1

1 reference

24 September 2017

1 May 1998

1 reference

24 September 2017

Neurochemical Research

1 reference

24 September 2017

23

1 reference

24 September 2017

787-794

1 reference

24 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022419712453

24 September 2017

0 references

cites work

Nicotinic Stimulation of [3H]Acetylcholine Release from Mouse Cerebral Cortical Synaptosomes

1 reference

12 December 2020

1 reference

12 December 2020

Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study

1 reference

12 December 2020

Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type

1 reference

12 December 2020

A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease.

1 reference

12 December 2020

Lewy bodies and response to tacrine in Alzheimer's disease.

1 reference

12 December 2020

Schizophrenia and nicotinic receptors.

1 reference

12 December 2020

Attention deficit in Alzheimer's disease is not simulated by an anticholinergic/antihistaminergic drug and is distinct from deficits in healthy aging.

1 reference

12 December 2020

Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.

1 reference

12 December 2020

Cholinomimetic treatment of Alzheimer's disease.

1 reference

12 December 2020

A pilot study of clonidine plus physostigmine in Alzheimer's disease

1 reference

12 December 2020

Alzheimer disease, attention, and the cholinergic system

1 reference

12 December 2020

Trans-synaptic stimulation of cortical acetylcholine and enhancement of attentional functions: a rational approach for the development of cognition enhancers

1 reference

12 December 2020

Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?

1 reference

12 December 2020

Nicotine effects on adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease.

1 reference

12 December 2020

Impairment of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movements.

1 reference

12 December 2020

Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system

1 reference

12 December 2020

Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.

1 reference

12 December 2020

Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

1 reference

12 December 2020

Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.

1 reference

12 December 2020

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

12 December 2020

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.

1 reference

12 December 2020

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

12 December 2020

Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.

1 reference

12 December 2020

Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease

1 reference

12 December 2020

1 reference

12 December 2020

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

1 reference

12 December 2020

Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease

1 reference

12 December 2020

Pharmacological treatment of cognitive dysfunction in dementia disorders.

1 reference

12 December 2020

Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications

1 reference

12 December 2020

Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele

1 reference

12 December 2020

A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele

1 reference

12 December 2020

Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats.

1 reference

12 December 2020

Distribution and some projections of cholinergic neurons in the brain of the common marmoset, Callithrix jacchus

1 reference

12 December 2020

Neuropsychology--dementia and affective disorders.

1 reference

12 December 2020

Alzheimer patients show a sensitivity decrement over time on a tonic alertness task.

1 reference

12 December 2020

Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers.

1 reference

12 December 2020

Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited

1 reference

12 December 2020

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

1 reference

12 December 2020

Clonidine treatment of Alzheimer's disease

1 reference

12 December 2020

The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions

1 reference

12 December 2020

Selective impairment of spatial attention during visual search in Alzheimer's disease.

1 reference

12 December 2020

The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type

1 reference

12 December 2020

The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.

1 reference

12 December 2020

Asymmetries in the covert orienting of visual spatial attention to spatial and non-spatial cues in Alzheimer's disease.

1 reference

12 December 2020

Effects of cholinergic blockade on language in healthy young women

1 reference

12 December 2020

Visuospatial attention in dementia of the Alzheimer type

1 reference

12 December 2020

Relation between nicotine intake and Alzheimer's disease

1 reference

12 December 2020

1 reference

12 December 2020

Cholinergic effects on constructional abilities and on mnemonic processes: a case report.

1 reference

12 December 2020

Basal forebrain lesions in monkeys disrupt attention but not learning and memory

1 reference

12 December 2020

Guanfacine treatment of Alzheimer's disease

1 reference

12 December 2020

The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients.

1 reference

12 December 2020

Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.

1 reference

12 December 2020

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

12 December 2020

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

12 December 2020

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

12 December 2020

The cholinergic hypothesis: a historical overview, current perspective, and future directions

1 reference

12 December 2020

Choline metabolism in cholinergic neurons: implications for the pathogenesis of neurodegenerative diseases

1 reference

12 December 2020

Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy.

1 reference

12 December 2020

The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease.

1 reference

12 December 2020

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Controlling the focus of spatial attention during visual search: effects of advanced aging and Alzheimer disease.

1 reference

12 December 2020

Alzheimer's disease: genotypes, phenotypes, and treatments

1 reference

12 December 2020

Longlasting improvement of Tourette's syndrome with transdermal nicotine

1 reference

12 December 2020

The autonomic-related cortex: pathology in Alzheimer's disease.

1 reference

12 December 2020

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

1 reference

12 December 2020

Nicotine may relieve symptoms of Parkinson's disease.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022419712453

1 reference

PubMed ID

9566619

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

9566619